Hemovigilance program-India

Akanksha Bisht1, Surinder Singh, Neelam Marwaha

  • 1Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India, Ghaziabad, India.

Insights

India launched a national hemovigilance program on December 10, 2012, to monitor blood transfusion adverse reactions and ensure patient safety. This initiative, coordinated by the National Institute of Biologicals, aims for nationwide coverage by 2016.

Area of Science:

  • Public Health
  • Pharmacovigilance
  • Medical Safety

Background:

  • Blood transfusion services require robust monitoring systems to ensure patient safety.
  • Adverse reactions to blood products can pose significant public health risks.
  • India lacked a centralized system for hemovigilance prior to 2012.

Purpose of the Study:

  • To establish a centralized hemovigilance program in India.
  • To monitor and report adverse reactions associated with blood transfusion and administration of blood products.
  • To promote patient safety and public health through improved blood product safety.

Main Methods:

  • Launch of a national hemovigilance program on December 10, 2012.
  • Inclusion of 60 medical colleges in the initial phase.
  • Integration with the Pharmacovigilance Program of India (PvPI).

Main Results:

  • A structured program for monitoring adverse reactions was established.
  • The National Institute of Biologicals (NIB) designated as the National Coordinating Centre.
  • Phased rollout aiming for enrollment of all medical colleges by 2016.

Conclusions:

  • The establishment of a centralized hemovigilance program is crucial for patient safety in India.
  • The program aims to create a global knowledge platform for hemovigilance at NIB.
  • Nationwide implementation will enhance the safety and efficacy of blood transfusion services.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Integrated Healthcare System01:20

Integrated Healthcare System

An integrated healthcare system (IHS) is a set of organizations that provides for or arranges to provide coordinated and continuous service to a defined population. The IHS takes responsibility for that particular population's health status and outcome, both clinically and fiscally. An integrated healthcare system is a well-organized, well-coordinated, and collaborative network. The integrated delivery system is a network that connects different healthcare providers to deliver organized,...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Secondary Healthcare System01:11

Secondary Healthcare System

Secondary healthcare is offered by a specialist, generally in hospitals or clinics for patients referred by primary healthcare providers. It occurs when a person has an illness or injury that requires specific medical care. Secondary care is often referred to as acute care. Secondary care can range from uncomplicated care to repair a minor laceration or treat a strep throat infection to more complicated emergent care, such as treating a head injury sustained in an automobile accident. Whatever...